Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany

References

• American Psychiatric Association. 2010. Practice guideline for the treatment of patients with major depressive disorder, Third Edition.
   Google Scholar
• Asay GRB, Roy K, Lang JE, Payne RL, Howard DH. 2016. Absenteeism and employer costs associated with chronic diseases and health risk factors in the US workforce. Prev Chronic Dis. 13:E141.
   PubMed Web of Science ®Google Scholar
• Becher H, Kostev K, Schröder-Bernhardi D. 2009. Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther. 47(10):617–626.
   PubMed Web of Science ®Google Scholar
• Birnbaum HG, Cremieux PY, Greenberg PE, Kessler RC. 2000. Management of major depression in the workplace: impact on employee work loss. Dis Manag Health Outcomes. 7(3):163–171.
   Google Scholar
• Bowling A. 1995. What things are important in people’s lives? A survey of the public’s judgements to inform scales of health related quality of life. Soc Sci Med. 41(10):1447–1462.
   PubMed Web of Science ®Google Scholar
• Bschor T, Baethge C. 2010. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy. Acta Psychiatr Scand. 121(3):174–179.
   PubMed Web of Science ®Google Scholar
• Bschor T, Kern H, Henssler J, Baethge C. 2018. Switching the antidepressant after nonresponse in adults with major depression: a systematic literature search and meta-analysis. J Clin Psychiatry. 79(1):16r10749.
   PubMed Web of Science ®Google Scholar
• Bültmann U, Rugulies R, Lund T, Christensen KB, Labriola M, Burr H. 2006. Depressive symptoms and the risk of long-term sickness absence: a prospective study among 4747 employees in Denmark. Soc Psychiat Epidemiol. 41(11):875–880.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, et al. 2018. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 391(10128):1357–1366.
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Chawla AJ, Kennedy S. 1999. Absenteeism among employees treated for depression. J Occup Environ Med. 41(7):605–611.
   PubMed Web of Science ®Google Scholar
• Dewa CS, Hoch JS, Lin E, Paterson M, Goering P. 2003. Pattern of antidepressant use and duration of depression-related absence from work. Br J Psychiatry. 183(6):507–513.
   PubMedGoogle Scholar
• DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, & DGPs, DGRW (Ed). 2009. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression.
   Google Scholar
• Ebrahim S, Guyatt GH, Walter SD, Heels-Ansdell D, Bellman M, Hanna SE, Patelis-Siotis I, Busse JW. 2013. Association of psychotherapy with disability benefit claim closure among patients disabled due to depression. PLoS One. 8(6):e67162.
   PubMed Web of Science ®Google Scholar
• Ehlken B, Shlaen M, Torres M. d P L F d, Hisada M, Bennett D. 2019. Use of azilsartan medoxomil in the primary-care setting in Germany: a real-world evidence study. Int J Clin Pharmacol Ther. 57(6):275–283.
   PubMed Web of Science ®Google Scholar
• Ervasti J, Joensuu M, Pentti J, Oksanen T, Ahola K, Vahtera J, Kivimaki M, Virtanen M. 2017. Prognostic factors for return to work after depression-related work disability: a systematic review and meta-analysis. J Psychiatr Res. 95:28–36.
   PubMed Web of Science ®Google Scholar
• Fagot J-P, Cuerq A, Samson S, Fagot-Campagna A. 2016. Cohort of one million patients initiating antidepressant treatment in France: 12-month follow-up. Int J Clin Pract. 70(9):744–751.
   PubMed Web of Science ®Google Scholar
• Freytag A, Krause M, Lehmann T, Schulz S, Wolf F, Biermann J, Wasem J, Gensichen J. 2017. Depression management within GP-centered health care – a case-control study based on claims data. Gen Hosp Psychiatry. 45:91–98.
   PubMed Web of Science ®Google Scholar
• Gaebel W, Kowitz S, Zielasek J. 2012. The DGPPN research project on mental healthcare utilization in Germany: inpatient and outpatient treatment of persons with depression by different disciplines. Eur Arch Psychiatry Clin Neurosci. 262(Suppl 2):S51–S55.
   PubMedGoogle Scholar
• Gasse C, Petersen L, Chollet J, Saragoussi D. 2013. Pattern and predictors of sick leave among users of antidepressants: a Danish retrospective register-based cohort study. J Affect Disord. 151(3):959–966.
   PubMed Web of Science ®Google Scholar
• Gili M, Roca M, Basu S, McKee M, Stuckler D. 2013. The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010. Eur J Public Health. 23(1):103–108.
   PubMed Web of Science ®Google Scholar
• Goetzel RZ, Gibson TB, Short ME, Chu B, Waddel J, Bowen J, Lemon SC, Fernandez ID, Ozminkowski RJ, Wilson MG, et al. 2010. A multi-worksite analysis of the relationships among body mass index, medical utilization, and worker productivity. J Occup Environ Med. 52(1S):S52–S58.
   PubMedGoogle Scholar
• Gordeev VS, Maksymowych WP, Schachna L, Boonen A. 2014. Understanding presenteeism in patients with ankylosing spondylitis: contributing factors and association with sick leave: presenteeism in ankylosing spondylitis. Arthritis Care Res. 66(6):916–924.
   Web of Science ®Google Scholar
• Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. 2005. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med. 143(6):415–426.
   PubMed Web of Science ®Google Scholar
• Hemels ME, Kasper S, Walter E, Einarson TR. 2004a. Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression. Ann Pharmacother. 38(6):954–960.
   PubMed Web of Science ®Google Scholar
• Hemels MEH, Kasper S, Walter E, Einarson TR. 2004b. Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria. Curr Med Res Opin. 20(6):869–878.
   PubMed Web of Science ®Google Scholar
• Hofmann SG, Curtiss J, Carpenter JK, Kind S. 2017. Effect of treatments for depression on quality of life: a meta-analysis. Cogn Behav Ther. 46(4):265–286.
   PubMed Web of Science ®Google Scholar
• Jeschke E, Ostermann T, Vollmar HC, Tabali M, Matthes H. 2012. Depression, comorbidities, and prescriptions of antidepressants in a german network of GPs and specialists with subspecialisation in anthroposophic medicine: a longitudinal observational study. Evid Based Complement Alternat Med. 2012:508623–508628.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Avedisova A, Belaïdi C, Picarel-Blanchot F, de Bodinat C. 2016. Sustained efficacy of agomelatine 10 mg, 25 mg, and 25–50 mg on depressive symptoms and functional outcomes in patients with major depressive disorder: a placebo-controlled study over 6 months. Eur Neuropsychopharmacol. 26(2):378–389.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Bromet EJ. 2013. The epidemiology of depression across cultures. Annu Rev Public Health. 34:119–138.
   PubMed Web of Science ®Google Scholar
• Krauth C, Stahmeyer JT, Petersen JJ, Freytag A, Gerlach FM, Gensichen J. 2014. Resource utilisation and costs of depressive patients in germany: results from the primary care monitoring for depressive patients trial. Depress Res Treat. 2014:730891.
   PubMedGoogle Scholar
• Lee Y, Rosenblat JD, Lee JG, Carmona NE, Subramaniapillai M, Shekotikhina M, Mansur RB, Brietzke E, Lee JH, Ho RC, et al. 2018. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: a systematic review. J Affect Disord. 227:406–415.
   PubMed Web of Science ®Google Scholar
• Merola D, Yong C, Noga SJ, Shermock KM. 2018. Costs associated with productivity loss among U.S. patients newly diagnosed with multiple myeloma receiving oral versus injectable chemotherapy. J Manag Care Spec Pharm. 24(10):1019–1026.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health (UK). 2010. Depression: the treatment and management of depression in adults (Updated Edition). London: British Psychological Society.
   Google Scholar
• Nieuwenhuijsen K, Bültmann U, Neumeyer ‐Gromen A, Verhoeven AC, Verbeek JH, Feltz‐Cornelis CM. 2008. Interventions to improve occupational health in depressed people. In: The Cochrane Collaboration, editor. Cochrane database of systematic reviews. New York: John Wiley & Sons, Ltd.
   Google Scholar
• Rathmann W, Bongaerts B, Carius H-J, Kruppert S, Kostev K. 2018. Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther. 56(10):459–466.
   PubMed Web of Science ®Google Scholar
• Roca M, Gili M, Garcia-Garcia M, Salva J, Vives M, Garcia Campayo J, Comas A. 2009. Prevalence and comorbidity of common mental disorders in primary care. J Affect Disord. 119(1–3):52–58.
   PubMed Web of Science ®Google Scholar
• Romera I, Pérez V, Menchòn JM, Schacht A, Papen R, Neuhauser D, Abbar M, Svanborg P, Gilaberte I. 2012. Early switch strategy in patients with major depressive disorder: a double-blind, randomized study. J Clin Psychopharmacol. 32(4):479–486.
   PubMed Web of Science ®Google Scholar
• Ruhé HG, Huyser J, Swinkels JA, Schene AH. 2006. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry. 67(12):1836–1855.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, et al. 2006. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 354(12):1231–1242.
   PubMed Web of Science ®Google Scholar
• Schosser A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Kasper S. 2012. European Group for the Study of Resistant Depression (GSRD)-where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmacol. 22(7):453–468.
   PubMed Web of Science ®Google Scholar
• Skoglund I, Bjorkelund C, Svenningsson I, Petersson E, Augustsson P, Nejati S, Ariai N, Hange D. 2019. Influence of antidepressant therapy on sick leave in primary care: ADAS, a comparative observational study. Heliyon. 5(1):e01101.
   PubMed Web of Science ®Google Scholar
• Stang P, Morris L, Kempf J, Henderson S, Yood MU, Oliveria S. 2007. The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events. Am J Ther. 14(1):30–40.
   PubMedGoogle Scholar
• Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. 2003. Cost of lost productive work time among US workers with depression. JAMA. 289(23):3135.
   PubMed Web of Science ®Google Scholar
• Tanislav C, Jacob L, Kostev K. 2021. Consultations decline for stroke, transient ischemic attack, and myocardial infarction during the COVID-19 pandemic in germany. Neuroepidemiology. 55(1):1–8.
   PubMed Web of Science ®Google Scholar
• Wang G, Gislum M, Filippov G, Montgomery S. 2015. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study. Curr Med Res Opin. 31(4):785–794.
   PubMed Web of Science ®Google Scholar
• Wedegärtner F, Sittaro N-A, Emrich H, Dietrich D. 2007. [Disability caused by affective disorders-what do the Federal German Health report data teach us?]. Psychiatr Prax. 34(Suppl 3):S252–S255.
   PubMedGoogle Scholar
• Wiegand HF, Sievers C, Schillinger M, Godemann F. 2016. Major depression treatment in Germany-descriptive analysis of health insurance fund routine data and assessment of guideline-adherence. J Affect Disord. 189:246–253.
   PubMed Web of Science ®Google Scholar
• Winkler D, Pjrek E, Moser U, Kasper S. 2007. Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria. Hum Psychopharmacol Clin Exp. 22(4):245–251.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2017. Depression and other common mental disorders global health estimates. Geneva: WHO.
   Google Scholar